​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Most Popular JCP Articles in the Past Week

  1. Dissociation in Pharmacokinetic Attenuation Between Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentration of Antipsychotics: A Systematic Review

    Shin Kurose, MD; Yu Mimura, MD; Hiroyuki Uchida, MD, PhD; Keisuke Takahata, MD, PhD; Euitae Kim, MD, PhD; Takefumi Suzuki, MD, PhD; Masaru Mimura, MD, PhD; and Hiroyoshi Takeuchi, MD, PhD

  2. Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review

    Michelle J. Blumberg, BScH; Sophie R. Vaccarino, BScH; and Shane J. McInerney, MD, MB, MSc, MRCPsych

  3. Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia

    Christoph U. Correll, MD, and John Lauriello, MD

  4. Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für #08#

    Georgios Schoretsanitis, MD, PhD; John M. Kane, MD; Christoph U. Correll, MD; Stephen R. Marder, MD; Leslie Citrome, MD, MPH; John W. Newcomer, MD; Delbert G. Robinson, MD; Donald C. Goff, MD; Deanna L. Kelly, PhD; Oliver Freudenreich, MD; Daria Piacentino, MD, PhD; Michael Paulzen, MD; Andreas Conca, MD; Gerald Zernig, MD; Ekkehard Haen, MD, PhD; Pierre Baumann, PhD; Christoph Hiemke, PhD; and Gerhard Gründer, MD; for the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie

  5. Increasing Emergency Department Visits for Mental Health Conditions in the United States

    Kayla M. Theriault, MPH; Robert A. Rosenheck, MD; and Taeho Greg Rhee, PhD, MSW

  6. Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

    Leslie L. Citrome, MD, MPH, and Stephen R. Saklad, PharmD, BCPP

  7. Current and Emerging Solutions to Challenges in the Management of Alzheimer’s Disease

    Alireza Atri, MD, PhD; Danielle Goldfarb, MD; Simon Sheard, DO; and Lynn Shaughnessy, PsyD

  8. Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

    John M. Kane, MD, and Christoph U. Correll, MD

  9. Psychiatric Side Effects of Chloroquine

    Florence Gressier, MD, PhD; Céline Verstuyft, MD, PhD; Laurent Becquemont, MD, PhD; Bruno Falissard, MD, PhD; and Emmanuelle Corruble, MD, PhD

  10. Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia

    Joseph P. McEvoy, MD, and Daniel E. Kremens, MD, JD